EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Nipro's Enterprise Value is 円731,164 Mil.
Nipro's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was 円0 Mil. Therefore, Nipro's EV-to-FCF for today is .
The historical rank and industry rank for Nipro's EV-to-FCF or its related term are showing as below:
TSE:8086'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.04 Med: 30.86 Max: 74.22
Current: 10.07
During the past 13 years, the highest EV-to-FCF of Nipro was 74.22. The lowest was 10.04. And the median was 30.86.
TSE:8086's EV-to-FCF is ranked better than 78.36% of 365
companies
in the Medical Devices & Instruments industry
Industry Median: 27.93
vs TSE:8086: 10.07
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-16), Nipro's stock price is 円1196.50.
Nipro's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was 円59.290. Therefore, Nipro's PE Ratio for today is 20.18.
Nipro EV-to-FCF Historical Data
The historical data trend for Nipro's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nipro's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nipro's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nipro's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Nipro's EV-to-FCF falls into.
Nipro's current Enterprise Value is 円731,164 Mil.
Nipro's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nipro (TSE:8086) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Nipro's share price for today is 円1196.50.
Nipro's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円59.290.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Nipro EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Nipro's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Nipro Corp develops medical devices, most of which are related to dialysis and artificial organs. The firm operates in four segments: medical, pharmaceutical, glass, and other. The medical segment contributes the majority of revenue. It sells products related to injections, infusions, artificial organs, and cell cultures, as well as medical equipment for renal treatment, diabetes, and generic drugs. Renal products contribute the largest proportion of sales within the medical segment. The pharmaceutical segment manufactures pharmaceuticals, including oral drugs and injectables, which are supplied to pharmaceutical companies in Japan. The glass business sells glass products used for medical applications, such as vials and syringes. Nipro generates the majority of its revenue in Japan.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:8086 has been successfully added to your 